23-valent Pneumococcal PolysaccharideVaccine

23-valent Pneumococcal PolysaccharideVaccine

Products and Business Services
23-valent Pneumococcal PolysaccharideVaccine
23-valent Pneumococcal PolysaccharideVaccine

Information

Covers a wider range of pneumococcal serotypesMore economical for low-and middle-income countries Patented process Great immunogenicity and safety Prefilled Syringe
Main Categories
APIs (Active Pharmaceutical Ingredients)Anatomical Therapeutic Chemical (ATC) Classification Products
Chongqing Zhifei Biological Products Co., Ltd.3.A14Chongqing Zhifei Biological Products Co., Ltd. is the largest listed vaccine company in China，which has its presence in biological product industry in 2002.The Company achieved an operating income of RMB38.3 billion In 2022 with the support of its nearly 7000 employees.As a high-tech biological enterprise integrating the R&D, production, marketing, distribution as well as import & export, Zhifei mainly engages in the production of vaccines for human use. Our research channels cover many indications extensively: like COVID-19, tuberculosis, meningitis, etc.

Join the event!

See all the content and easy-to-use features by logging in or registering!